Brown v. Inch

CourtDistrict Court, M.D. Florida
DecidedMay 14, 2021
Docket3:19-cv-00997
StatusUnknown

This text of Brown v. Inch (Brown v. Inch) is published on Counsel Stack Legal Research, covering District Court, M.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Brown v. Inch, (M.D. Fla. 2021).

Opinion

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA JACKSONVILLE DIVISION

PERRY BROWN,

Plaintiff,

v. Case No. 3:19-cv-997-BJD-MCR

THE FLORIDA DEPARTMENT OF CORRECTIONS, CORIZON, LLC, and CENTURION OF FLORIDA, LLC,

Defendants.

ORDER I. Status Plaintiff, Perry Brown, an inmate in the custody of the Florida Department of Corrections, initiated this action by filing a pro se Civil Rights Complaint (Doc. 1) under 42 U.S.C. § 1983. He is proceeding on an Amended Complaint (Doc. 14; AC), filed with help from court appointed counsel on August 12, 2020. As Defendants, Plaintiff sues the Florida Department of Corrections (FDOC); Corizon, LLC (Corizon); and Centurion of Florida, LLC (Centurion). AC at 2-3. Plaintiff, who alleges he suffers from Hepatitis C virus (HCV), argues that Defendants Corizon and Centurion violated his Eighth Amendment right to be free from cruel and unusual punishment and that Defendant FDOC violated Title II of the Americans with Disabilities Act (ADA) and Section 504 of the Rehabilitation Act (RA) when Defendants refused to

provide Plaintiff with lifesaving HCV treatment under a cost-saving policy. Id. at 15-20. As relief, Plaintiff seeks declaratory relief, compensatory and punitive damages, as well as attorney’s fees and costs. Id. at 21. Before the Court is Defendant Corizon’s Motion to Dismiss, in which

Corizon argues that Plaintiff failed to exhaust his administrative remedies before filing the instant lawsuit.1 See Defendant Corizon, LLC’s Motion to Dismiss the Amended Complaint (Doc. 41; Motion). Plaintiff filed a Response in opposition to the Motion. See Perry Brown’s Response to Defendant

Corizon’s Motion to Dismiss (Doc. 51; Response). The Motion is ripe for review. II. Plaintiff’s Allegations In his AC, Plaintiff raises four counts. See generally AC. Plaintiff alleges in Counts I and II that Corizon and Centurion, respectively, were deliberately

indifferent to his serious medical needs and denied him necessary treatment for his chronic HCV, in violation of the Eighth Amendment. AC at 1. In Count III, Plaintiff alleges that the FDOC violated the ADA by discriminating against him based on his disability when it withheld medical treatment while not

withholding medical treatment from prisoners with other disabilities or who

1 Defendants FDOC and Centurion each filed an Answer in response to the Amended Complaint. See Docs. 40, 46. were not disabled. Id. at 15-19. Finally, in Count IV, Plaintiff asserts that the FDOC violated the RA when it excluded Plaintiff from receiving lifesaving

HCV treatment “solely by reason of his disability.” Id. at 19-20. Because the matter currently before the Court only pertains to Plaintiff’s allegations against Corizon, the Court limits its summary to those allegations. Plaintiff alleges that Corizon, an out-of-state corporation registered to do

business in Florida, contracted with the FDOC from October 2012 until May 2016 to provide health care services to prisoners in FDOC custody, including Plaintiff who is housed at Union Correctional Institution. Id. at 3. Plaintiff alleges that he entered FDOC custody on November 27, 2006. Id. at 7. Though

it is unclear when Plaintiff received his diagnosis, he contends that when he entered FDOC custody, he suffered from chronic HCV, a blood-borne disease. Id. at 3-7. He maintains that chronic HCV is a serious medical need, causing liver inflammation, liver fibrosis, cirrhosis, and possible death. Id. at 3.

Plaintiff asserts that in 2013, a new class of drugs known a direct-acting antivirals (DAAs) became available to HCV patients. Id. at 5. He argues that DAAs are oral medications with few side effects that cure HCV at a rate over 95%. Id. According to Plaintiff, in 2014, the American Association for the Study

of Liver Diseases and the Infectious Disease Society of America recommended DAA treatment for all persons with chronic HCV. Id. And since 2014, DAA treatment “has been the standard of care for the treatment of HCV . . . .” Id. Plaintiff contends that despite DAAs becoming available in 2013, Defendants failed to provide these lifesaving medications to thousands of HCV positive

prisoners, in contravention of the prevailing standard of care. Id. at 6. Plaintiff argues that Corizon officials knew about DAAs when the medication became available in 2013 and knew DAA treatment was the medical standard of care and treatment for chronic HCV. Id. at 7. He also

contends that Corizon knew that thousands of FDOC prisoners suffered from HCV, but it refused to provide DAAs or any other treatment for the virus. Id. Plaintiff argues that he underwent a physical exam when he entered prison in 2011, during which FDOC physicians informed Plaintiff that his HCV infection

had caused decompensated cirrhosis. Id. at 7. According to Plaintiff, he underwent further medical tests in September 2011, November 2012, September 2013, August 2014, February 2015, May 2016, and July 2016, all of which confirmed that his decompensated cirrhosis had increasingly advanced.

Id. at 7-8. For nearly four years, however, Plaintiff asserts that Corizon knew Plaintiff had chronic HCV but refused to provide him with DAA treatment despite knowing that his condition prioritized him for such treatment. Id. at 8. According to Plaintiff, Corizon denied him HCV treatment from July

2013 until May 2016 because Corizon and the FDOC “had a policy, practice, and custom of not providing [DAAs] to patients with HCV, in part to save costs and to make larger profits.” Id. at 9. He argues that as a result of Corizon’s practice, policy, and custom of refusing to treat Plaintiff with DAAs from July 2013 to May 2016, “he sustained serious damage to his health and an increased

risk of future health complication.” Id. Plaintiff maintains Defendant Centurion replaced Corizon as the FDOC’s contracted health care vendor in May 2016, but Centurion continued to deny Plaintiff DAA treatment. According to Plaintiff, he did not receive treatment until October 9, 2017;

however, because all Defendants delayed his treatment, he continues to sustain serious damage to his health and irreparable damage to his liver. Id. at 11. III. Summary of Parties’ Positions on Exhaustion

In its Motion, Corizon argues that Plaintiff failed to exhaust his administrative remedies for his Eighth Amendment claim against it, as required by the Prison Litigation Reform Act (PLRA), before filing the instant § 1983 lawsuit. Motion at 1. According to Corizon, it provided medical services

in certain Florida prisons from September 2013 until it cancelled its contract in May 2016. Id. at 2. Corizon maintains that Plaintiff was cured of his “disease on October 9, 2017.” Id. at 2. Corizon contends that while Plaintiff filed “a single qualifying grievance . . . on December 7, 2018,” (id. at 2 (citing Doc. 1-

1)), Plaintiff’s efforts were insufficient to exhaust any claim against Corizon because “the grievance was filed two years [and] seven months after Corizon ceased providing services in any Florida prison and more than a year after he was cured of the disease” (id. at 2). Corizon argues that because Plaintiff failed to file a grievance while Corizon was still providing medical services to FDOC

prisoners, the grievance Plaintiff filed did not place Corizon on notice or give it a chance to resolve the issue. Id. at 7. Therefore, according to Corizon, the grievance was not adequate to exhaust Plaintiff’s claims against Corizon. Id. Plaintiff asserts that he exhausted his claim against Corizon because he

completed all necessary steps of the FDOC’s grievance procedure and the grievances adequately addressed Corizon’s delay in providing medical treatment.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Neal Horsley v. Gloria Feldt
304 F.3d 1125 (Eleventh Circuit, 2002)
Goebert v. Lee County
510 F.3d 1312 (Eleventh Circuit, 2007)
Bryant v. Rich
530 F.3d 1368 (Eleventh Circuit, 2008)
Turner v. Burnside
541 F.3d 1077 (Eleventh Circuit, 2008)
Woodford v. Ngo
548 U.S. 81 (Supreme Court, 2006)
Jones v. Bock
549 U.S. 199 (Supreme Court, 2007)
Parzyck v. Prison Health Services, Inc.
627 F.3d 1215 (Eleventh Circuit, 2010)
Ellis v. Vadlamudi
568 F. Supp. 2d 778 (E.D. Michigan, 2008)
Moliere Dimanche, Jr. v. Jerry Brown
783 F.3d 1204 (Eleventh Circuit, 2015)
Shawn Wayne Whatley v. Warden, Ware State Prison
802 F.3d 1205 (Eleventh Circuit, 2015)
Ross v. Blake
578 U.S. 632 (Supreme Court, 2016)
John Pavao v. Sims
679 F. App'x 819 (Eleventh Circuit, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
Brown v. Inch, Counsel Stack Legal Research, https://law.counselstack.com/opinion/brown-v-inch-flmd-2021.